High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: A phase I trial

M. Tempero, P. Leichner, G. Dalrymple, K. Harrison, S. Augustine, J. Schlam, J. Anderson, J. Wisecarver, D. Colcher

Research output: Contribution to journal › Article › peer-review